Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

The role of insulin receptors and IGF-I receptors in cancer and other diseases.

Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R.

Arch Physiol Biochem. 2008 Feb;114(1):23-37. doi: 10.1080/13813450801969715 . Review.

PMID:
18465356
2.

Standardization of C-peptide measurements.

Little RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, Myers GL, Greenbaum CJ, Palmer JP, Rogatsky E, Stein DT.

Clin Chem. 2008 Jun;54(6):1023-6. doi: 10.1373/clinchem.2007.101287. Epub 2008 Apr 17.

3.

Obesity is not predictive of overall survival following permanent prostate brachytherapy.

Merrick GS, Galbreath RW, Butler WM, Wallner KE, Allen ZA, Adamovich E.

Am J Clin Oncol. 2007 Dec;30(6):588-96.

PMID:
18091052
4.

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.

Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH, Pollak M.

J Natl Cancer Inst. 2007 Dec 5;99(23):1793-800. Epub 2007 Nov 27.

PMID:
18042933
5.

Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.

BaƱez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, Wang Y, Terris MK, Aronson WJ, Presti JC Jr, Kane CJ, Amling CL, Moul JW, Freedland SJ.

JAMA. 2007 Nov 21;298(19):2275-80.

PMID:
18029831
6.

Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

Efstathiou JA, Bae K, Shipley WU, Hanks GE, Pilepich MV, Sandler HM, Smith MR.

Cancer. 2007 Dec 15;110(12):2691-9.

7.

Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer.

Palma D, Pickles T, Tyldesley S; Prostate Cohort Outcomes Initiative.

BJU Int. 2007 Aug;100(2):315-9.

9.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Gallina A, Karakiewicz PI, Hutterer GC, Chun FK, Briganti A, Walz J, Antebi E, Shariat SF, Suardi N, Graefen M, Erbersdobler A, Salonia A, Rigatti P, Huland H, Montorsi F.

Int J Cancer. 2007 Aug 15;121(4):791-5.

10.

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study.

Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC.

Int J Cancer. 2007 Oct 1;121(7):1571-8.

11.

Anthropometrics and prostate cancer risk.

Littman AJ, White E, Kristal AR.

Am J Epidemiol. 2007 Jun 1;165(11):1271-9. Epub 2007 Mar 28.

PMID:
17395597
12.
13.

Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.

Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B, Hallmans G, Kaaks R, Stattin P.

Int J Cancer. 2007 Jun 15;120(12):2678-86.

14.

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality.

Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, Hurwitz P, Hollenbeck A, Leitzmann MF.

Cancer. 2007 Feb 15;109(4):675-84.

15.

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.

Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):63-9. Epub 2006 Dec 19.

16.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Chun FK, Briganti A, Graefen M, Erbersdobler A, Walz J, Schlomm T, Meschke M, Haese A, Valiquette L, Huland H, Karakiewicz PI.

Eur J Cancer. 2007 Jan;43(2):375-82. Epub 2006 Dec 1.

PMID:
17141497
17.

Trends in hyperinsulinemia among nondiabetic adults in the U.S.

Li C, Ford ES, McGuire LC, Mokdad AH, Little RR, Reaven GM.

Diabetes Care. 2006 Nov;29(11):2396-402.

PMID:
17065674
18.

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.

Keating NL, O'Malley AJ, Smith MR.

J Clin Oncol. 2006 Sep 20;24(27):4448-56.

PMID:
16983113
19.

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis.

MacInnis RJ, English DR.

Cancer Causes Control. 2006 Oct;17(8):989-1003.

PMID:
16933050
20.

Tumor metastasis: mechanistic insights and clinical challenges.

Steeg PS.

Nat Med. 2006 Aug;12(8):895-904. Review. No abstract available.

PMID:
16892035

Supplemental Content

Support Center